Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study

BACKGROUND: Osteonecrosis is common in systemic lupus erythematosus (SLE) and often disabling. The role of glucocorticoids in its development is well known. OBJECTIVE: To explore other possible risk factors for osteonecrosis in SLE. METHODS: A nested matched case–control study undertaken in the cont...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Calvo‐Alén, J, McGwin, G, Toloza, S, Fernández, M, Roseman, J M, Bastian, H M, Cepeda, E J, González, E B, Baethge, B A, Fessler, B J, Vilá, L M, Reveille, J D, Alarcón, G S
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2006
Assuntos:
Extended Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1798170/
https://ncbi.nlm.nih.gov/pubmed/16269429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.040428
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares